Cargando…

Association of anticoagulation use with SARS-CoV2 detection()

• Patients who warrant chronic warfarin can safely continue warfarin therapy with precautions during the COVID-19 pandemic. • Chronic warfarin therapy is not associated with a higher rate of positively testing for SAR-CoV2. • Patients on warfarin during the COVID-19 pandemic maintained TTR rates con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kavecansky, Juraj, Dusendang, Jennifer R., Tavakoli, Jahan, Schmittdiel, Julie, Ho, Gwendolyn, Loyles, Jodi, Pai, Ashok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709610/ https://www.ncbi.nlm.nih.gov/pubmed/33310348 http://dx.doi.org/10.1016/j.thromres.2020.11.034

Ejemplares similares

Association of Anticoagulant Use with COVID-19 Diagnosis
por: Kavecansky, Juraj, et al.
Publicado: (2020)

Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
por: Ho, Gwendolyn, et al.
Publicado: (2021)

Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients
por: Ho, Gwendolyn, et al.
Publicado: (2020)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)

Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
por: Hsu, Andrew, et al.
Publicado: (2020)

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
por: Franchini, Massimo, et al.
Publicado: (2023)

Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
por: Catella, Judith, et al.
Publicado: (2022)

The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort
por: Lynn, Lei, et al.
Publicado: (2021)

Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021)

Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group
por: Ray, Joel G., et al.
Publicado: (2021)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease
por: Ruzicka, Jan A.
Publicado: (2020)

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
por: Ageno, Walter, et al.
Publicado: (2021)

Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil
por: Machado, Kendra Lys Calixto, et al.
Publicado: (2021)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic
por: Speed, V., et al.
Publicado: (2020)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial
por: Pantet, Olivier, et al.
Publicado: (2023)

Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update
por: Franchini, Massimo, et al.
Publicado: (2023)

Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine
por: Leone, Maria Cristina, et al.
Publicado: (2022)

Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg
por: Pizzolo, Francesca, et al.
Publicado: (2020)

Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study
por: Velayos, Fernando S., et al.
Publicado: (2021)

Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
por: Angelika, Wagner, et al.
Publicado: (2022)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

Covid-19 vaccination, adverse events, and detection of antibodies
por: Kristensen, Søren Risom, et al.
Publicado: (2021)

SARS‐CoV‐2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California
por: Anantharaman, Archana, et al.
Publicado: (2020)

Detection of anti-GPIbα autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination
por: Nakamura, Takayuki, et al.
Publicado: (2022)

High mobility group box 1 (HMGB 1): a new protein in the pathogenesis of ENT inflammatory and infectious diseases
por: PASSALI, D., et al.
Publicado: (2012)

Role of H.E.L.P.-apheresis in the treatment of sudden sensorineural hearing loss in a group of 230 patients
por: BIANCHIN, G., et al.
Publicado: (2011)

Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization
por: Rajendram, Rajkumar, et al.
Publicado: (2020)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
por: Torres-Machorro, Adriana, et al.
Publicado: (2020)

More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism
por: van Dam, L.F., et al.
Publicado: (2020)

Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units
por: Doyle, Andrew J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h66vknkil2bvlca9j5ppup4pul